Newborn screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency in Bihar: A pressing priority in today's time

Background and Objective: Newborn screening (NBS) aims towards early detection of congenital disorders or prevention of intellectual and physical defects and life-threatening illness. Three disorders namely congenital hypothyroidism (CH), congenital adrenal hyperplasia (CAH) and glucose-6-phosphate...

Full description

Bibliographic Details
Main Authors: Bandana Kumari, Khushboo Raj, Sadhana Sharma, Sushil Kumar, Bhabesh K Chowdhry, Amit Kumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2023;volume=12;issue=12;spage=3332;epage=3338;aulast=Kumari
_version_ 1797232682025877504
author Bandana Kumari
Khushboo Raj
Sadhana Sharma
Sushil Kumar
Bhabesh K Chowdhry
Amit Kumar
author_facet Bandana Kumari
Khushboo Raj
Sadhana Sharma
Sushil Kumar
Bhabesh K Chowdhry
Amit Kumar
author_sort Bandana Kumari
collection DOAJ
description Background and Objective: Newborn screening (NBS) aims towards early detection of congenital disorders or prevention of intellectual and physical defects and life-threatening illness. Three disorders namely congenital hypothyroidism (CH), congenital adrenal hyperplasia (CAH) and glucose-6-phosphate dehydrogenase deficiency (G-6-PDD) were selected for a preliminary study for NBS. The study aimed to establish NBS in the Indian scenario that could lay a framework for future such initiatives. Methods: A screening programme was conducted at a tertiary care hospital for 1 year. All the neonates born at All India Institute of Medical Sciences (AIIMS), Patna, were screened for their blood levels of glucose-6-phosphate dehydrogenase (G-6-PD), 17-hydroxyprogesterone (17-OHP) and thyroid-stimulating hormone (TSH). Heel-prick blood samples were collected within 48–72 h of birth, and the level of these parameters was accessed by enzyme immunoassay (EIA). Results: A total of 492 neonates were born from January 2020 to December 2020, of which 369 newborns were screened for CAH, CH and G-6-PDD. Of 369 neonates, one case (male) had an increased level of TSH, six cases (all males) had an increased level of 17-OHP and no case was found with G-6-PDD. Interpretation and Conclusions: Preliminary data on the prevalence of various genetic disorders revealed that CAH is the most prevalent disorder followed by CH in the population of Bihar. More efforts need to be undertaken to create awareness and to make screening a successful programme in India. A cost-effective nationwide screening programme is highly recommended for the detection of such cases at the earliest to avoid their future complication.
first_indexed 2024-04-24T16:04:09Z
format Article
id doaj.art-96aab0456b7544449d08b9c988228f70
institution Directory Open Access Journal
issn 2249-4863
language English
last_indexed 2024-04-24T16:04:09Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Family Medicine and Primary Care
spelling doaj.art-96aab0456b7544449d08b9c988228f702024-04-01T06:00:31ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632023-01-0112123332333810.4103/jfmpc.jfmpc_1029_23Newborn screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency in Bihar: A pressing priority in today's timeBandana KumariKhushboo RajSadhana SharmaSushil KumarBhabesh K ChowdhryAmit KumarBackground and Objective: Newborn screening (NBS) aims towards early detection of congenital disorders or prevention of intellectual and physical defects and life-threatening illness. Three disorders namely congenital hypothyroidism (CH), congenital adrenal hyperplasia (CAH) and glucose-6-phosphate dehydrogenase deficiency (G-6-PDD) were selected for a preliminary study for NBS. The study aimed to establish NBS in the Indian scenario that could lay a framework for future such initiatives. Methods: A screening programme was conducted at a tertiary care hospital for 1 year. All the neonates born at All India Institute of Medical Sciences (AIIMS), Patna, were screened for their blood levels of glucose-6-phosphate dehydrogenase (G-6-PD), 17-hydroxyprogesterone (17-OHP) and thyroid-stimulating hormone (TSH). Heel-prick blood samples were collected within 48–72 h of birth, and the level of these parameters was accessed by enzyme immunoassay (EIA). Results: A total of 492 neonates were born from January 2020 to December 2020, of which 369 newborns were screened for CAH, CH and G-6-PDD. Of 369 neonates, one case (male) had an increased level of TSH, six cases (all males) had an increased level of 17-OHP and no case was found with G-6-PDD. Interpretation and Conclusions: Preliminary data on the prevalence of various genetic disorders revealed that CAH is the most prevalent disorder followed by CH in the population of Bihar. More efforts need to be undertaken to create awareness and to make screening a successful programme in India. A cost-effective nationwide screening programme is highly recommended for the detection of such cases at the earliest to avoid their future complication.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2023;volume=12;issue=12;spage=3332;epage=3338;aulast=Kumaricongenital adrenal hyperplasiacongenital hypothyroidismglucose-6-phosphate dehydrogenase deficiencynewborn screening
spellingShingle Bandana Kumari
Khushboo Raj
Sadhana Sharma
Sushil Kumar
Bhabesh K Chowdhry
Amit Kumar
Newborn screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency in Bihar: A pressing priority in today's time
Journal of Family Medicine and Primary Care
congenital adrenal hyperplasia
congenital hypothyroidism
glucose-6-phosphate dehydrogenase deficiency
newborn screening
title Newborn screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency in Bihar: A pressing priority in today's time
title_full Newborn screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency in Bihar: A pressing priority in today's time
title_fullStr Newborn screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency in Bihar: A pressing priority in today's time
title_full_unstemmed Newborn screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency in Bihar: A pressing priority in today's time
title_short Newborn screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency in Bihar: A pressing priority in today's time
title_sort newborn screening for congenital hypothyroidism congenital adrenal hyperplasia and glucose 6 phosphate dehydrogenase deficiency in bihar a pressing priority in today s time
topic congenital adrenal hyperplasia
congenital hypothyroidism
glucose-6-phosphate dehydrogenase deficiency
newborn screening
url http://www.jfmpc.com/article.asp?issn=2249-4863;year=2023;volume=12;issue=12;spage=3332;epage=3338;aulast=Kumari
work_keys_str_mv AT bandanakumari newbornscreeningforcongenitalhypothyroidismcongenitaladrenalhyperplasiaandglucose6phosphatedehydrogenasedeficiencyinbiharapressingpriorityintodaystime
AT khushbooraj newbornscreeningforcongenitalhypothyroidismcongenitaladrenalhyperplasiaandglucose6phosphatedehydrogenasedeficiencyinbiharapressingpriorityintodaystime
AT sadhanasharma newbornscreeningforcongenitalhypothyroidismcongenitaladrenalhyperplasiaandglucose6phosphatedehydrogenasedeficiencyinbiharapressingpriorityintodaystime
AT sushilkumar newbornscreeningforcongenitalhypothyroidismcongenitaladrenalhyperplasiaandglucose6phosphatedehydrogenasedeficiencyinbiharapressingpriorityintodaystime
AT bhabeshkchowdhry newbornscreeningforcongenitalhypothyroidismcongenitaladrenalhyperplasiaandglucose6phosphatedehydrogenasedeficiencyinbiharapressingpriorityintodaystime
AT amitkumar newbornscreeningforcongenitalhypothyroidismcongenitaladrenalhyperplasiaandglucose6phosphatedehydrogenasedeficiencyinbiharapressingpriorityintodaystime